A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.

References

1. Thackway S. Health surveillance during the Sydney 2000 Olympic and paralympic games. NSW Public Health Bulletin 2000;11:142-145.

2. Kennett M, Brussen KA, Wood DJ, van der Avoort HG, Ras A, Kelly HA. Australia's last reported case of wild poliovirus infection. Commun Dis Intell 1999;23:77-79.

3. Torzillo PJ, Gratten M. Conjugate pneumococcal vaccines for Aboriginal children in Australia. Med J Aust 2000;173:S51-S53.

4. Black S, Shinefield H, Fireman B. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000;19:187-195.

5. Kirk M. OzFoodNet: enhancing surveillance of foodborne disease across Australia. Microbiology Australia 2001;:28-29.

6. National Health and Medical Research Council. Surveillance case definitions. Canberra: National Health and Medical Research Council; 1994.

7. Ponnuthurai A, Hall R. Annual report of the National Notifiable Diseases Surveillance System, 1991. Commun Dis Intell 1992;16:334-346.

8. Hall R. Annual report of the National Notifiable Diseases Surveillance System, 1992. Commun Dis Intell 1993;17:502-511.

9. Longbottom H, Evans D, Myint H, Hargreaves J. Annual report of the National Notifiable Diseases Surveillance System, 1993. Commun Dis Intell 1994;18:518-548.

10. Hargreaves J, Longbottom H, Myint H. Annual report of the National Notifiable Diseases Surveillance System, 1994. Commun Dis Intell 1995;19:542-574.

11. Herceg A, Oliver G, Myint H. Annual report of the National Notifiable Diseases Surveillance System, 1995. Commun Dis Intell 1996;20:440-464.

12. Curran M, Harvey B, Crerar S. Annual report of the National Notifiable Diseases Surveillance System, 1996. Commun Dis Intell 1997;21:281-307.

13. O'Brien E, D'Souza R, Gilroy N. Australia's notifiable diseases status, 1997. Commun Dis Intell 1999;23:1-27.

14. Thomson J, Lin M, Halliday L, Preston G, McIntyre P, Gidding H, et al. Australia's notifiable diseases status, 1998. Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 1999;23:277-305.

15. Roche P, Spencer J, Lin M, Gidding H, Kirk M, Eyeson-Annan M, et al. Australia's notifiable diseases status, 1999. Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2001;25:190-245.

16. Spencer J, Dore G, Robotin M, Correll P, Kaldor J. Outcomes from the first two years of the Australian hepatitis C surveillance strategy. Commun Dis Intell 2002;26:14-22.

17. Hsu HH, Feinstone SM, Hoofnagle JH. Acute viral hepatitis. In: Mandell GL, Bennett JE, Dolin R, Principles and Practice of Infectious Diseases. 4th edition. New York: Churchill Livingstone,1995:1136-1153.

18. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, et al. Food-related illness and death in the United States. Emerging Infectious Diseases 1999;5:607-625.

19. Wheeler JG, Sethi D, Cowden JM, Wall PG, Rodrigues LC, Tompkins DS, et al. Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. BMJ 1999;318:1046-1050. Top of page

20. Allos BM. Campylobacter jejuni infections: update on emerging issues and trends. Clinical Infectious Diseases 2001;32:1201-1206.

21. Joint FAO/WHO expert consultation on risk assessment of microbiological hazards in foods. Risk characterization of Salmonella spp in eggs and broiler chickens and Listeria monocytogenes in ready to eat foods. Rome: FAO; 2001 May 2001.

22. McCarthy N, Giesecke J. Incidence of Guillain-Barré syndrome following infection with Campylobacter jejuni. Am J Epidemiol 2001;153:610-614.

23. Highlights for October 2000. Commun Dis Intell 2000;24:349.

24. Highlights for November 2000. Commun Dis Intell 2000;24:391.

25. National Health and Medical Research Council. The Australian immunisation handbook. 7th ed. Canberra: Australian Government Publishing Services; 2000.

26. Conaty S, Bird P, Bell G, Kraa E, Grohmann G, McAnulty JM. Hepatitis A in New South Wales, Australia, from consumption of oysters: the first reported outbreak. Epidemiology and Infection 2000;124:121-130.

27. Chin J. Control of Communicable Diseases Manual. 7th ed. Washington: American Public Health Association; 2000.

28. Bull AL, Crerar SK, Beers MY. Australia's imported food program - a valuable source of information on micro-organisms in foods. Commun Dis Intell 2002;26:28-32.

29. National Enteric Pathogen Surveillance Scheme human annual report, 2000. Melbourne: University of Melbourne; 2001 February 2001.

30. Tribe IG, Walker J. An outbreak of Salmonella Typhimurium phage type 44 linked to a restaurant in South Australia. Commun Dis Intell 2000;24:347.

31. Lesjak M, Delpech V, Ferson M, Morgan K, Paraskevopoulos P, McAnulty J. A Salmonella Mgulani cluster in New South Wales. Commun Dis Intell 2000;24:305-306.

32. Menzies R. Shigellosis outbreak among inner-Sydney men. Commun Dis Intell 2000;24:247.

33. Cameron S, Walker C, Beers M, Rose N, Anear E. Enterohaemorrhagic Escherichia coli outbreak in South Australia associated with consumption of mettwurst. Commun Dis Intell 1995;19:70-71.

34. Food policy in the National Centre for Disease Control. Commun Dis Intell 2000;24:95.

35. Kirk M. OzFoodNet: enhancing foodborne disease surveillance across Australia: quarterly report, January to March 2001. Commun Dis Intell 2001;25:103-106.

36. McDonald A, Musto J. Annual surveillance report. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia. Sydney: National Centre in HIV Epidemiology and Clinical Research; 2001.

37. Miller P. Donovanosis control or eradication? A situational review of donovanosis in Aboriginal and Torres Strait Islander populations in Australia. Canberra: Commonwealth of Australia; 2001.

38. Donovan B. What is the gonococcus telling us? Commun Dis Intell 1998;22:216-217.

39. Donovan B, Bodsworth NJ, Rohrsheim R, McNulty A, Tapsall JW. Increasing gonorrhoea - not only in London. Lancet 2000;355:1908.

40. Tapsall J. Annual report of the Australian Gonococcal Surveillance Programme, 2000. Commun Dis Intell 2001;25:59-63.

41. Tapsall J. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2000. Commun Dis Intell 2001;25:274-277.

42. O'Brien ED, Sam GA, Mead C. Methodology for measuring Australia's childhood immunisation coverage. Commun Dis Intell 1998;22:36-37.

43. Hall R. Notifiable disease surveillance, 1917 to 1991. Commun Dis Intell 1993;17:226-236.

44. Baker M, Taylor P, Wilson E, Jones N, Short P. A case of diphtheria in Auckland - implications for disease control. New Zealand Public Health Report 1998;5:73-76.

45. Vitek CR, Wharton M. Diphtheria in the Former Soviet Union: re-emergence of a pandemic disease. Emerging Infectious Diseases 1998;4:539-550.

46. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clinical Microbiology Reviews 2000;13:302-317.

47. World Health Organization. Measles: Progress towards global control and regional elimination 1998-1999. WER 1999;74:429-440.

48. Gay NJ. Eliminating measles - no quick fix. WHO Bulletin 2000;78:949.

49. Gilbert GL, Escott RG, Gidding HF. Impact of the Australian Measles Control Campaign on immunity to measles and rubella. Epidemiol Infect 2001;127:297-303. Top of page

50. de Serres G, Gay NJ, Farrington CP. Epidemiology of transmissible diseases after elimination. Am J Epidemiol 2000;151:1039-1048.

51. Hanna J, Richards A, Young D, Hills S, Humphreys J. Measles in health care facilities: some salutary lessons. Commun Dis Intell 2000;24:211-212.

52. Andrews R. Measles outbreak among young adults in Victoria. Commun Dis Intell 2001;25:12.

53. Lambert SB, Kelly HA, Andrews RM, Catton MC, Lynch PA, Leydon JA, et al. Enhanced measles surveillance during the inter-epidemic period in Victoria. Med J Aust 2000;172:114-118.

54. Hewlett EL. Bordetella species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 4th ed. New York: Churchill Livingstone; 1995:2078-2084.

55. Mooi FR, van Loo IHM, King AJ. Adaptation of Bordetella pertussis to vaccination: a cause for its re-emergence? Emerging Infectious Diseases 2001;7:526-528.

56. Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clinical Infectious Diseases 2001;32:1691-1697.

57. Department of Health and Aged Care. National documentation for certification of poliomyelitis eradication in Australia. Canberra: Commonwealth of Australia; 2000.

58. WHO. Major milestone reached in global polio eradication: Western Pacific Region is certified polio-free. Commun Dis Intell 2000;24:304.

59. Spencer JD, Azoulas J, Buick TD, Daniels PW, Doggett SL, Hapgood GD, et al. Murray Valley encephalitis virus surveillance and control initiatives in Australia. Commun Dis Intell 2001;25:33-48.

60. Flexman JP, Smith DW, Mackenzie JS, Fraser JRE, Bass SP, Hueston L, et al. A comparison of the diseases caused by Ross River virus and Barmah Forest virus. Med J Aust 1998;169:159-163.

61. Mackenzie JS, Broom AK, Hall RA, Johansen CA, Lindsay MD, Phillips DA, et al. Arboviruses in the Australian region, 1990 to 1998. Commun Dis Intell 1998;22:93-100.

62. Mackenzie JS, Smith DW. Mosquito-borne viruses and epidemic polyarthritis. Med J Aust 1996;164:90-93.

63. McBride WJ, Bielefeldt-Ohmann H. Dengue viral infections; pathogenesis and epidemiology. Microbes Infect 2000;2:1041-1050.

64. Cordova SP, Gilles MT, Beers MY. The outbreak that had to happen: Bordetella pertussis in the North-West Western Australia in 1999. Commun Dis Intell 2000;24:375-379.

65. Broom A, Sturrock K, van Heuzen B, Lindsay M, Smith D. Seroconversions in sentinel chickens provide an early warning of Murray Valley encephalitis virus activity in Western Australia. Arbovirus Research 2001;8:43-47.

66. Walker J. Malaria in a changing world: an Australian perspective. Int J for Parasitol 1998;28:947-953.

67. Kitchener SJ, Auliff AM, Rieckmann KH. Malaria in the Australian Defence Force during and after participation in the International Force in East Timor. Med J Aust 2000;173:583-585.

68. Ertem M, Kuecki AE, Aysev D, Unal E, Ikinciogullari A. Brucellosis transmitted by bone marrow transplantation. Bone Marrow Transplantation 2000;26:225-226.

69. Bishara J, Robenshtok E, Weinberger M, Yeshurun M, Sagie A, Pitlik S. Infective endocarditis in renal recipients. Transplant Infectious Diseases 1999;1:138-143. Top of page

70. Palanduz A, Palanduz S, Guler K, Guler N. Brucellosis in a mother and her young infant. Int J Infect Dis 2000;4:55-56.

71. Paton NI, Tee NW, Vu CK, Teo TP. Visceral abscesses due to Brucella suis infection in a retired pig farmer. Clinical Infectious Diseases 2001;32:E129-130.

72. Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, Bryne WR, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997;278:399-411.

73. Sider F, Takafuji E, Franz D. Medical aspects of chemical and biological warfare. Washington DC: US Department of Health and Human Services, Office of the Surgeon General; 1997.

74. Leggiadro RJ. The threat of biological terrorism: a public health and infection control reality. Infect Control Hosp Epidemiol 2000;21:53-56.

75. Robson JM, Harrison MW, Wood RN, Tilse MH, McKay AB, Brodribb TR. Brucellosis: re-emergence and changing epidemiology in Queensland. Med J Aust. 1993;159:153-158.

76. Campos-Bueno A, Lopez-Abente G, Andres-Cercadillo AM. Risk factors for Echinococcus granulosis infection: a case control study. Am Trop Med Hyg 2000;62:329-334.
77. Jenkins DJ, Power K. Human hydatidosis in New South Wales and the Australian Capital Territory, 1987-1992. Med J Aust 1996;164:18-21.

78. McCullagh PJ. Hydatid disease: medical problems, veterinary solutions, political obstacles. Med J Aust 1996;164:7-8.

79. Emanuel ML, Mackarras IM, Smith DJW. The epidemiology of leptospirosis in North Queensland: general survey of animal hosts. J Hyg (Camb) 1964;62:451-484.

80. Centers for Disease Control and Prevention. Outbreak of acute febrile illness among athletes participating in Eco-challenge Sabah 2000. MMWR 2001;52:21-24.

81. Krause V. Special surveillance report - cases of leptospirosis in hunters in the Top End - don't go barefoot. Comm Dis Intell 2000;24:384.

82. Williams J, Tallis G, Dalton C, Ng S, Beaton S, Catton M, et al. Community outbreak of psittacosis in a rural Australian town. Lancet 1998;351:1697-1699.

83. Maurin M, Raoult D. Q fever. Clin Microbiol Rev 1999;12:518-553.

84. Casolin A. Q fever in New South Wales Department of Agriculture workers. Journal of Occupational and Environmental Medicine 1999;41:273-278.

85. Marmion BP, Ormsbee RA, Kyrkou M, Wright J, Worswick D, Cameron S, et al. Vaccine prophylaxis of abattoir-associated Q fever. Lancet 1984(Dec 22):1411-1414.

86. Gilroy N, Formica N, Beers M, Egan A, Conaty S, Marmion B. Abattoir-associated Q fever: a Q fever outbreak during a Q fever vaccination program. Aust N Z J Public Health 2001;25:362-367.

87. Hutson B, Deaker RA, Newland J. Vaccination of cattle workers at risk of Q fever on the north coast of New South Wales. Aust Fam Physician 2000;29:708-709.

88. Yu VL. Legionella pneumophila (Legionnaires' disease). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Fourth ed. New York: Churchill Livingstone; 1995:2087-2097.

89. Steele TW. Legionella in South Australia. Commun Dis Intell 1989;13:2-3.

90. Cameron S, Walker C, Roden D. Epidemiological characteristics of Legionella infection in South Australia: implications for disease control. Aust N Z J Med 1991;21:65-70.

91. Ruehlmann SA, Crawford GR. Panic in the potting shed. The association between Legionella longbeachae serogroup 1 and potting soils in Australia. Med J Aust 1996;164:36-38.

92. Steele TW, Moore CV, Sangster N. Distribution of Legionella longbeachae serogroup 1 and other Legionellae in potting soils in Australia. Appl Environ Microbiol 1990;56:2984-2988.

93. Kirk M. Disease activity in Victoria. Commun Dis Intell 2000;24:72.

94. Legionnaires' disease outbreak in Victoria. Commun Dis Intell 2000;24:92.

95. DHS. Surveillence of notifiable disease in Victoria 2000. Melbourne: Department of Human Services, State Government of Victoria; 2001.

96. World Health Organization. Meningococcal Disease. In: WHO Report on global surveillance of epidemic-prone infectious diseases. Geneva; 2000.

97. World Health Organization. Control of epidemic meningococcal disease; WHO practical guidelines. 2nd edition. Geneva, Switzerland.: WHO.; 2000.

98. Baker MG, Martin DR, Kieft CE, Lennon D. A 10-year meningococcal epidemic in New Zealand: descriptive epidemiology, 1991-2000. J Paediat Child Health 2001;37:S13-19.

99. Herf C, Nichols J, Fruh S, Holloway B, Anderson CU. Meningococcal disease recognition, treatment and prevention. Nurse Practitioner 1998;23:33-36. Top of page

100. Roche P, Spencer J, Merianos A. Editorial: Meningococcal disease. Commun Dis Intell 2001;25:126-129.

101. Patel MS, Merianos A, Hanna JN. Epidemic meningococcal meningitis in central Australia. Med J Aust 1993;158:336-40.

102. Ferson M, Young L, Hansen G, Post J, Tapsall J, Schultz T, et al. Unusual cluster of mild invasive serogroup C meningococcal infection in a university college. Commun Dis Intell 1999;23:261-264.

103. Jelfs J, Jalaludin B, Munro R, Patel M, Kerr M, Daley D, et al. A cluster of meningococcal disease in western Sydney initially associated with a nightclub. Epidemiol Infect 1998;120:263-270.

104. Skull SA, Butler JRG, Robinson P, Carnie J. Should programmes for community level meningococcal vaccination be considered in Australia? An economic evaluation. Int J. Epidemiol 2001;30:571-578.

105. Tapsall J. Annual report of the Australian Meningococcal Surveillance Programme, 2000. Commun Dis Intell 2002;26:xx-xx.

106. Lin M, Spencer J, Roche P, McKinnon M. Tuberculosis notifications in Australia, 2000. Commun Dis Intell 2002;26:xx-xx.

107. Lumb R, Bastian I. Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2000: Report of the Australian Mycobacterium Laboratory Reference Network. Commun Dis Intell 2002;26:xx-xx.

108. Harley D, Harrower B, Lyon M, Dick A. A primary school outbreak of pharyngoconjunctival fever caused by adenovirus type 3. Commun Dis Intell 2001;25:9-12.

109. Masendycz P, Bogdanovic-Sakran N, Kirkwood C, Bishop R, Barnes G. Report of the Australian Rotavirus Surveillance Programme 2000/2001. Commun Dis Intell 2001;25:143-146.

110. Stambos V, Brussen K, Turnbull A, Ibrahim A, Kennett M. Report of the Australian National Polio Reference Laboratory: 1 January to 30 June 2000. Commun Dis Intell 2000;24:300-303.

111. Stambos V, Brussen K, Turnbull A, Thorley B, Kennett M. Report of the Australian National Polio Reference Laboratory: 1 July to 31 December 2000. Commun Dis Intell. 2001;25:54-58.

112. Allars M. Inquiry into the use of pituitary derived hormones in Australia and Creutzfeldt-Jakob disease. Report - June 1994. Australian Government Publishing Service. Canberra; 1994.


This article was published in Communicable Diseases Intelligence Volume 26, No 2, June 2002